The role of carnitine supplementation in valproic acid therapy.
Kelley
R I
RI
D002331:Carnitine / Q000172:deficiency / Q000627:therapeutic use*; D002648:Child; D004311:Double-Blind Method; D044943:Fatty Acid Desaturases / Q000172:deficiency; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000188:drug therapy; D014635:Valproic Acid / Q000009:adverse effects / Q000627:therapeutic use*
D014635:Valproic Acid; D044943:Fatty Acid Desaturases; D002331:Carnitine